Funder
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference90 articles.
1. Liu, J. T. & Sanai, N. Trends and challenges for the clinical adoption of fluorescence-guided surgery. J. Nucl. Med. 60, 756–757 (2019).
2. Pogue, B. W. Perspective on the optics of medical imaging. J. Biomed. Opt. 28, 121208–121208 (2023).
3. Sutton, P. A. et al. Fluorescence-guided surgery: comprehensive review. BJS Open 7, zrad049 (2023).
4. Teng, C. W. et al. Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgery. J. Neurosurg. 135, 1026–1035 (2021).
5. Li, M. et al. 800CW dye and 89Zr dual-labeled antibody for the PET/NIRF/Cerenkov multi-modality imaging of ICAM-1 (CD54) in pancreatic cancer. J. Nucl. Med. 60, 331 (2019).